RecruitingNot ApplicableNCT06853756

Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia

Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia: a Prospective Randomized Trial


Sponsor

Tanta University

Enrollment

60 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Our study aimed to compare the gastric insufflation volume between Ambu AuraGain and i-gel and its relationship with the oropharyngeal sealing pressure and the incidence of postoperative complications in generally anesthetized controlled-ventilated pediatric patients undergoing elective orthopedic operations.


Eligibility

Min Age: 2 YearsMax Age: 12 Years

Inclusion Criteria4

  • Aged from 2 to 12 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I and II.
  • Scheduled for elective orthopedic operations in a supine position under general anesthesia.

Exclusion Criteria6

  • Patients with a known history of gastro-oesophageal reflux disorders.
  • Full Stomach.
  • Anticipated difficult mask ventilation or intubation.
  • Body mass index "BMI" exceeding 20% of the ideal.
  • A history of chest problems.
  • History of the gastrointestinal tract or thoracic surgeries.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAmbu Auragain

Ambu Auragain was inserted after induction.

DEVICEI-gel

The I-gel device was inserted after induction.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06853756


Related Trials